SEC Form 4 · accession 0001437749-18-017390
BioCardia, Inc. · BCDA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Peter Altman
Officer — President and CEO · Director
Period of report
Sep 12, 2018
Accepted (ET)
Sep 24, 2018 · 9:40 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000925741
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 12, 2018 | P | 100 | $1.40 | A | 713,442 | D | |
| Common Stock | Sep 17, 2018 | P | 200 | $1.58 | A | 713,642 | D | |
| Common StockF1 | Sep 20, 2018 | P | 800 | $1.823 | A | 714,442 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This transaction was executed in multiple trades at prices ranging from $1.71 to $1.99 per share. The price reported above reflects the weighted average per share purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer full information regarding the number of shares purchased at each separate price.